Regulated Information

Regulated Information
Shareholders’ Meeting

Period

Filter by

Reset

Showing: 1 – 05 of 166 Regulated Information

Show

Sort

Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline

15 December 2025

Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline

PARIS, FRANCE, 15 December 2025 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced it has completed the acquisition of ImCheck Therapeutics, a private French biotechnology company pioneering next-generation immuno-oncology therapies.

IPSEN - Buy-back programme - Art 5 of MAR - Week 49- 2025

09 December 2025

IPSEN – Buy-back programme – Art 5 of MAR – Week 49- 2025

Ipsen - November 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital

08 December 2025

Ipsen – November 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital

Monthly information relative to the total number of voting rights and shares composing the share capital

IPSEN - Buy-back programme - Art 5 of MAR - Week 48 - 2025

02 December 2025

IPSEN – Buy-back programme – Art 5 of MAR – Week 48 – 2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 47 - 2025

25 November 2025

IPSEN – Buy-back programme – Art 5 of MAR – Week 47 – 2025

1 2 3 4 … 34